Date |
Time |
Source |
Heading |
5/30/2024 | 15:05 | EDGAR2 | Form 8-K - Current report |
5/29/2024 | 15:05 | GLOBE | TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq.. |
5/28/2024 | 15:59 | EDGAR2 | Form 4/A - Statement of changes in beneficial ownership of.. |
5/23/2024 | 16:00 | EDGAR2 | Form 8-K - Current report |
5/17/2024 | 16:05 | EDGAR2 | Form PRE 14A - Other preliminary proxy statements |
5/15/2024 | 15:30 | EDGAR2 | Form NT 10-Q - Notification of inability to timely file Form.. |
4/23/2024 | 15:05 | GLOBE | TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq.. |
3/06/2024 | 07:30 | EDGAR2 | Form 8-K - Current report |
3/06/2024 | 07:05 | GLOBE | TRxADE Health, Inc. Announces Special Cash Dividend |
2/16/2024 | 16:05 | EDGAR2 | Form 8-K - Current report |
2/14/2024 | 13:50 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
1/17/2024 | 08:07 | GLOBE | Trxade health, Inc files its 3Q 10Q |
1/17/2024 | 08:05 | EDGAR2 | Form 8-K - Current report |
1/16/2024 | 15:05 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
1/16/2024 | 05:12 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
1/11/2024 | 16:25 | EDGAR2 | Form 8-K - Current report |
11/29/2023 | 17:13 | GLOBE | TRxADE Announces Receipt of Notification of Deficiency from.. |
11/28/2023 | 11:29 | EDGAR2 | Form 8-K - Current report |
11/15/2023 | 12:51 | EDGAR2 | Form NT 10-Q - Notification of inability to timely file Form.. |
10/17/2023 | 07:05 | GLOBE | TrxADE Health, Inc. affirms its commitment to the.. |
10/13/2023 | 12:25 | EDGAR2 | Form 8-K - Current report |
10/12/2023 | 07:05 | GLOBE | Superlatus Announces Distribution Partnership with North.. |
10/11/2023 | 15:05 | EDGAR2 | Form 8-K - Current report |
10/04/2023 | 08:29 | EDGAR2 | Form 8-K - Current report |
10/04/2023 | 07:05 | GLOBE | Superlatus, Newly Merged with TRxADE HEALTH, Acquires the.. |
9/25/2023 | 07:06 | EDGAR2 | Form PRER14A - Preliminary Proxy Soliciting materials |
9/14/2023 | 16:28 | EDGAR2 | Form 8-K - Current report |
9/08/2023 | 09:42 | EDGAR2 | Form PRER14A - Preliminary Proxy Soliciting materials |
9/07/2023 | 07:05 | GLOBE | Superlatus Announces Planned Expansion into Pet Food Market |
8/25/2023 | 05:15 | EDGAR2 | Form 8-K - Current report |
8/24/2023 | 08:47 | EDGAR2 | Form 8-K - Current report |
8/24/2023 | 07:05 | GLOBE | Superlatus Innovates $151 Billion US Snacking Market with.. |
8/22/2023 | 07:05 | GLOBE | Superlatus, Newly Merged with TRxADE HEALTH, Agrees to.. |
8/18/2023 | 15:05 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
8/14/2023 | 09:25 | GLOBE | TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing |
8/14/2023 | 07:30 | EDGAR2 | Form NT 10-Q - Notification of inability to timely file Form.. |
8/14/2023 | 05:20 | EDGAR2 | Form PRE 14A - Other preliminary proxy statements |
8/03/2023 | 08:05 | GLOBE | Newly merged Entity Superlatus, Inc with Trxade Health, Inc... |
7/31/2023 | 08:40 | EDGAR2 | Form 8-K - Current report |
7/31/2023 | 07:35 | GLOBE | TRxADE HEALTH, Inc. Announces Closing of Acquisition of.. |
7/14/2023 | 16:08 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
7/14/2023 | 16:07 | EDGAR2 | Form 8-K - Current report |
7/14/2023 | 15:30 | GLOBE | TRxADE HEALTH, Inc. Amends Definitive Merger Agreement with.. |
7/10/2023 | 15:58 | EDGAR2 | Form 8-K - Current report |
6/30/2023 | 08:25 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
6/30/2023 | 08:25 | EDGAR2 | Form 8-K - Current report |
6/30/2023 | 07:05 | GLOBE | Superlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive.. |
6/27/2023 | 07:00 | GLOBE | Superlatus, Inc. Announces New Appointments to the.. |
6/23/2023 | 15:40 | GLOBE | TRxADE HEALTH, Inc. Issues Correction to Press Release.. |
6/23/2023 | 07:05 | GLOBE | Superlatus, Inc. to Combine with TRxADE HEALTH, Inc., to.. |